Welcome to the UCSF Immunoprofiler.

 

The mission of the UCSF Immunoprofiler is to develop a translational platform to enhance treatment efficacy, develop precision medicines, and understand the immunological basis for cancer.

We propose that cancers are ultimately discrete forms of immunopathology. By understanding the nature of the immune response, we will determine how to treat cancers and provide new targets for the next round of immunotherapies.

Find out more about us and how you can help.

 
 

OUR MISSION

Find out more about our organization, mission, and methods.

Learn More →

FOR PATIENTS

Contribute to our coordinated and cutting-edge analysis of cancer.

Find Out How →

 

New 'Immunoprofiler' Initiative will advance drug discovery, precision immunotherapy for cancer (UCSF News Center)

January 19, 2017
 

UCSF Immunoprofiler begins to profile breast cancers and sarcomas.

January 4, 2017

UCSF Immunoprofiler begins to profile prostate cancers.

December 16, 2017

Abbvie officially joins the UCSF Immunoprofiler consortium.

October 11, 2016

August 15, 2016
 

Investigators at the UCSF Immunoprofiler discover prognostic indicators within human melanoma cancers (Link).

August 8, 2016
 

Investigators at the UCSF Immunoprofiler discover new mechanisms that the immune system uses to recognize tumors (Link).